Skip to main content

Table 4 Comparison of the serum concentrations of UCP2 at before and after the intervention

From: The effect of omega3 fatty acid supplementation on PPARγ and UCP2 expressions, resting energy expenditure, and appetite in athletes

Variable Omega-3 Group (n = 18) Placebo Group (n = 18) MD (95% CI), P
Ucp2 (ng/L)
 Before 15.6 (11.5, 27.9) 15.2 (11.8, 28.1) 0.37(− 0.47, 0.42), 0.91b
 After 22.1 (13.4, 29.4) 14.9 (10.4, 17.8) 7.17 (4.02, 12.8), 0.04 c
 MD (95% CI), pa 6.48 (3.08, 7.73), 0.01 −0.32 (0.12, 0.49), 0.01  
  1. UCP2 uncoupling protein2; Mean (standard deviation), and mean difference (95% CI)
  2. a based on Wilcoxon signed-rank test
  3. b based on Mann–Whitney U test
  4. c based on Quantile regression adjusted for baseline values